M8 PHARMA Trademark

Trademark Overview


On Thursday, April 20, 2023, a trademark application was filed for M8 PHARMA with the United States Patent and Trademark Office. The USPTO has given the M8 PHARMA trademark a serial number of 97898449. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, May 21, 2024. This trademark is owned by Moksha8 Pharmaceuticals, Inc.. The M8 PHARMA trademark is filed in the Advertising, Business and Retail Services and Computer & Software Services & Scientific Services categories with the following description:

Consultation services related to sales management, sales promotion, and sales methods of biotechnology and pharmaceutical products and therapies

Development of pharmaceutical products and therapies; consultation services related to development of biotechnology and pharmaceutical products and therapies
m8 pharma

General Information


Serial Number97898449
Word MarkM8 PHARMA
Filing DateThursday, April 20, 2023
Status688 - NOTICE OF ALLOWANCE - ISSUED
Status DateTuesday, May 21, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 26, 2024

Trademark Statements


Pseudo MarkM EIGHT PHARMA; MOKSHA EIGHT PHARMACEUTICALS
Goods and ServicesConsultation services related to sales management, sales promotion, and sales methods of biotechnology and pharmaceutical products and therapies
NOT AVAILABLE"PHARMA"
Goods and ServicesDevelopment of pharmaceutical products and therapies; consultation services related to development of biotechnology and pharmaceutical products and therapies

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateMonday, January 1, 0001
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, May 16, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameMoksha8 Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBerwyn, PA 19312

Party NameMoksha8 Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBerwyn, PA 19312

Trademark Events


Event DateEvent Description
Monday, June 26, 2023NON-FINAL ACTION E-MAILED
Monday, April 24, 2023NEW APPLICATION ENTERED
Tuesday, May 16, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, June 26, 2023ASSIGNED TO EXAMINER
Monday, June 26, 2023NON-FINAL ACTION WRITTEN
Monday, June 26, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, September 26, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, February 16, 2024ASSIGNED TO LIE
Friday, February 16, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, February 16, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, February 16, 2024EXAMINERS AMENDMENT -WRITTEN
Friday, February 16, 2024EXAMINERS AMENDMENT E-MAILED
Friday, February 16, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, February 16, 2024EXAMINER'S AMENDMENT ENTERED
Friday, February 16, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 6, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, March 6, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 26, 2024PUBLISHED FOR OPPOSITION
Tuesday, March 26, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Friday, August 23, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, August 23, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, August 23, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, August 23, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, May 21, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT